Mechanical Stimulation of the Ovary for Infertility Treatment in Patients With Very Low Ovarian Reserve

Sponsor
Sheba Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT03298750
Collaborator
(none)
10
1
22.4

Study Details

Study Description

Brief Summary

Examine the possibility that mechanical stimulation and ovarian fragmentation in women with premature ovarian failure or low ovarian reserve intended for egg donation may cause early follicular recruitment and increase chances of achieving pregnancy through IVF.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Resection of ovarian tissue and mechanical stimulation
N/A

Detailed Description

The women will undergo a surgical laparoscopy during which one of the two technique will ensue.

  1. One of the ovaries will be scratched ( 2 mm depth) with a knife. Simultaneously, a piece of the ovary will be preserved for further histologic analysis and research in the laboratory.

  2. A piece of one ovary will be resected (up to one third of the ovary's volume, without harming the other ovary.

The resected ovarian tissue will be transferred immediately to the laboratory where the cortex will be divided from the medulla and sliced to small pieces of 1-2 square millimeters.

These pieces will be transferred back to the operation room in order for them to be transplanted under the serosa layer of the remaining ovary.

Any bleeding would be stopped using a stiches or hemostatic mesh (diathermy will not be used).

Simultaneously, a piece of the ovary will be preserved for further histologic analysis and research in the laboratory.

Post operational follow up ( up to two years) including: menstrual cycle surveillance, hormonal profile, AMH level, US of the pelvis and Antral Follicles Count (AFC).

A month after the surgery, an ovarian stimulation will commence following IVF while close monitoring the ovarian response and comparing the pre and post operation response.

Moreover, the treated ovary will be compared to the untreated one: using the US the ovarian volume and antral follicles size and count will be evaluated.

The preserved pieces of ovary will be histologically evaluated for ovarian reserve analysis.

Additionally, these pieces will be used for experiments for the evaluation of various methods for primordial follicles stimulation including mechanical stimulation like the laser or using substances like Akt Stimulators.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Mechanical Stimulation of the Ovary for Infertility Treatment in Patients With Very Low Ovarian Reserve
Anticipated Study Start Date :
Oct 20, 2017
Anticipated Primary Completion Date :
Sep 1, 2019
Anticipated Study Completion Date :
Sep 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mechanical stimulation

Mechanical stimulation of ovarian tissue

Procedure: Resection of ovarian tissue and mechanical stimulation
he women will undergo a surgical laparoscopy during which one of the two technique will ensue. One of the ovaries will be scratched ( 2 mm depth) with a knife. Simultaneously, a piece of the ovary will be preserved for further histologic analysis and research in the laboratory. A piece of one ovary will be resected (up to one third of the ovary's volume, without harming the other ovary. The resected ovarian tissue will be transferred immediately to the laboratory where the cortex will be divided from the medulla and sliced to small pieces of 1-2 square millimeters. These pieces will be transferred back to the operation room in order for them to be transplanted under the serosa layer of the remaining ovary. Any bleeding would be stopped using a stiches or hemostatic mesh (diathermy will not be used). Simultaneously, a piece of the ovary will be preserved for further histologic analysis and research in the laboratory.

Outcome Measures

Primary Outcome Measures

  1. Menstrual cycle surveillance [2 years]

    Duration of the menstrual period (days)

  2. AMH [2 years]

    Ovarian reserve measurements. AMH levels ng/ml

  3. Estradiol [2 years]

    Estradiol levels at day of HCG in Pmol/L

  4. Antral follicular count [2 years]

    measurement of. any antral follicles at day 3-5 with ultrasound

  5. IVF outcomes [2 years]

    Number of oocytes at OPU

  6. FSH levels [2 years]

    FSH levels at. day 2-3 of menstruation IU/L

  7. IVF outcomes fertilization rates [2 years]

    fertilization rate. - number of fertilized oocytes relatively to total number of oocytes

  8. IVF outcomes [2 years]

    pregnancy rates

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy women, aged 21-40. with premature ovarian failure.

  • Healthy women, with poor ovarian reserve, aged 38-45, undergoing IVF Low ovarian response: recruitment of up to three eggs in previous treatments.

  • After the failure of at least 4 cycles.

  • Two functioning ovaries, follicular and hormonal response of both ovaries in prior therapies.

  • Women candidates for egg donation, and seeking further treatment before switching to egg donation.

Exclusion Criteria:
  • Women with kidney disease.

  • Women with infertility factors other than ovarian failure, such as endometriosis, PCOS, male factor.

  • Women with one non-functioning ovary, or that was removed.

  • Women with an intrauterine or pelvic pathology.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Sheba Medical Center

Investigators

  • Principal Investigator: Alon Kedem, MD, Sheba Medical Center, Israel

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT03298750
Other Study ID Numbers:
  • SHEBA-15-2289-AK-CTIL
First Posted:
Oct 2, 2017
Last Update Posted:
Oct 10, 2017
Last Verified:
Oct 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sheba Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 10, 2017